Financials
Financial year 2025
DEFOPHARMA from Lessines, company number BE0732501933, closed financial year 2025 with a result of € 18,298 after tax. For that financial year DEFOPHARMA recorded a gross margin of € 23,185 and equity of € 84,881. Compared with financial year 2024, the result moved from € 18,613 to € 18,298. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 22, 2026.
€ 84,881
▲ 27% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 18,298
▼ 2% vs 2024
Profit after tax over the fiscal year.
€ 516
▲ 62% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 72,481.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
€ 56,750
▼ 14% vs 2024
€ 9,267 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 5,200
Supplier invoices still open on the last day of the fiscal year.
€ 21,980
▲ 1% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
| 2021 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 8,962 | € 15,719 | € 23,109 | € 23,185 | |
| Profit after taxes | € 4,048 | € 16,074 | € 18,613 | € 18,298 | ▼ 2% |
| Equity | € 21,844 | € 47,970 | € 66,583 | € 84,881 | ▲ 27% |
| Total debts | € 114,272 | € 115,513 | € 105,461 | € 96,546 | ▼ 8% |
| Cash | € 21 | € 88 | € 318 | € 516 | ▲ 62% |
| Retained profit | € 9,444 | € 35,570 | € 54,183 | € 72,481 | ▲ 34% |
| Bank debt | € 91,323 | € 74,005 | € 65,835 | € 56,750 | ▼ 14% |
| Balance sheet total | € 136,115 | € 163,482 | € 172,044 | € 181,427 | ▲ 5% |
Key figures of DEFOPHARMA, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DEFOPHARMA?
What happened at DEFOPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 18,298 (▼ 2% vs 2024). filed late Source: NBB ↗
- New establishment in Elsene. KBO
- Start of the company according to the CBE. KBO
In short
From € 4,048 profit in 2021 to € 18,298 profit in 2025.
Paid € 7,792 in corporate taxes since 2021.
Best year ever: 2024, with € 18,613 profit.
Management
Behind DEFOPHARMA is Victor Djouguela Defo. It owns 100% of Pharmacie Arnaud Nicolas itself.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Boulevard Emile Schevenels(L) 34
7860 Lessines
Raadstraat 44
1050 Elsene
Active since 1 September 2019
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0732.501.933
- VAT number
- BE 0732.501.933
- Registered office
- Boulevard Emile Schevenels(L) 34, 7860 Lessines
- Names & denominations
- DEFOPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 August 2019
- Peppol
- Active · Active since 27 Jan 2026
- Contact
- [email protected] +3225127598
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering